Podcast discusses longevity science, biological age tests and clinic practice
In this podcast description, geroscientist Prof. Brian Kennedy discusses moving longevity science into clinical practice, including mTOR and rapamycin, biological age testing, ovarian aging and peptides. [1]
Automatic summary · not editorially reviewed
The key findings
The description lists mTOR and rapamycin, CA-AKG, biological age testing, ovarian aging, menopause-delaying research, peptides, gene therapies and longevity clinics as episode topics. [1]
According to the description, Kennedy warns that combining too many supplements may unintentionally over-suppress essential cellular pathways. [1]
The description says Kennedy explains why many commercial biological age tests remain inconsistent and why personalized measurement matters. [1]
The source at a glance
- Study type / format
- Podcast episode description
- Population / context
- Listeners of the described podcast episode with Prof. Brian Kennedy
- Summary based on
- Creator description
- Original publication
- August 8, 2026
Topics listed for the Kennedy podcast episode
The description says this is episode 123 of the Sober Head Podcast, hosted by Dr. Esra Çavuşoğlu, PhD, with Prof. Brian Kennedy. It lists mTOR and rapamycin, CA-AKG, biological age testing, ovarian aging, menopause-delaying research, peptides, gene therapies and the growing longevity clinic industry as topics. It also says Kennedy warns that combining too many supplements may unintentionally over-suppress essential cellular pathways.
Supporting source [1]
Biological age tests and peptides in the description
The description states that Kennedy explains why many commercial biological age tests remain inconsistent and why personalized measurement matters. It also says he explains how peptides could become some of the most important longevity medicines of the future. These are topics attributed to the episode; the description gives no test results, effect sizes or study details.
Supporting source [1]
Singapore initiative and health-shift framing
The description mentions Singapore’s $300 million healthy longevity initiative and says the episode discusses why healthcare must shift from treating disease to preserving health and performance throughout life. It also includes a promotional discount code and a link to a company site; these are commercial elements of the description, not findings.
Supporting source [1]
How to interpret this
This explainer is based only on the video description. The video and transcript were not reviewed, so no study designs, results or effect sizes can be confirmed.
Based on the creator’s description; the full video and transcript were not analyzed.
Source & supporting passages
Ayık Kafa · youtube.com · August 8, 2026